Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Non-cash Items: 2016-2024

Historic Non-cash Items for Intellia Therapeutics (NTLA) over the last 9 years, with Dec 2024 value amounting to $350,000.

  • Intellia Therapeutics' Non-cash Items fell 0.12% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 0.12%. This contributed to the annual value of $350,000 for FY2024, which is 99.03% down from last year.
  • As of FY2024, Intellia Therapeutics' Non-cash Items stood at $350,000, which was down 99.03% from $35.9 million recorded in FY2023.
  • In the past 5 years, Intellia Therapeutics' Non-cash Items ranged from a high of $35.9 million in FY2023 and a low of $350,000 during FY2024.
  • Moreover, its 3-year median value for Non-cash Items was $3.2 million (2022), whereas its average is $13.2 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first skyrocketed by 1,016.73% in 2023, then crashed by 99.03% in 2024.
  • Over the past 5 years, Intellia Therapeutics' Non-cash Items (Yearly) stood at $3.0 million in 2020, then decreased by 24.50% to $2.2 million in 2021, then soared by 44.39% to $3.2 million in 2022, then soared by 1,016.73% to $35.9 million in 2023, then tumbled by 99.03% to $350,000 in 2024.